Laura Pizzuti - Concepedia

Author

Laura Pizzuti

National Cancer Institute ORCID

Also Known As

L Pizzuti, L. M. Pizzuti, L. Pizzuti, Laura Micol Pizzuti, Laura Pizzuti, Pizzuti, L., Pizzuti, Laura Micol

192

Publications

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute Istituti di Ricovero e Cura a Carattere Scientifico University of Chieti-Pescara Sapienza University of Rome Università Cattolica del Sacro Cuore

About

Laura Pizzuti is an author at National Cancer Institute specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	632
2	Health Sciences	4	4	129
3	Cell Biology	3	3	64
4	Public Health	2	2	39
5	Engineering	1	1	49

Laura Pizzuti

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden Daniele Marinelli, Marco Mazzotta, Stefano Scalera, Annals of Oncology MedicineLung AdenocarcinomaImmunologyPathologyCancer Genomics	2020	218
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients Vincenzo Graziano, Antonino Grassadonia, Laura Iezzi, The Breast	2019	170
The sexist behaviour of immune checkpoint inhibitors in cancer therapy? Andrea Botticelli, Concetta Elisa Onesti, Ilaria Grazia Zizzari, Oncotarget	2017	112
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B Martina Musella, Andrea Guarracino, Nicoletta Manduca, Nature Immunology	2022	107
Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic carcinoma. Piero Alò, Mostafa M. Amini, F. Piro, PubMed	2007	78
KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy Stefano Scalera, Marco Mazzotta, Giacomo Corleone, Journal of Thoracic Oncology Tp53 Frame GenomicCancer ImmunosurveillanceLung AdenocarcinomaImmunologyPathology	2021	76
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study Giulia Bon, Laura Pizzuti, Valentina Laquintana, Journal of Experimental & Clinical Cancer Research	2020	72
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas Claudia Abbruzzese, Stefano Mattarocci, Laura Pizzuti, Journal of Experimental & Clinical Cancer Research	2012	71
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience Patrizia Vici, Laura Pizzuti, Andrea Michelotti, Oncotarget	2017	68
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab Andrea Botticelli, Massimiliano Salati, Francesca Romana Di Pietro, Journal of Translational Medicine	2019	63

Page 1